We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| LAVA Therapeutics NV | NASDAQ:LVTX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.0301 | -0.99% | 2.9999 | 2.80 | 3.00 | 3.09 | 2.78 | 3.03 | 115,102 | 00:47:31 |
From May 2023 to May 2024
By Sabela Ojea
Lululemon Athletica on Thursday raised its outlook for the year amid significant sales growth in China. Shares of the athletic-gear maker climbed 13%, to $371.67, in after-hours trading.
Lava Therapeutics on Thursday said a lead candidate aimed at an undisclosed tumor-associated antigen was selected for further development toward clinical studies by Janssen Biotech. Shares of the biotechnology company surged 26%, to $2.40, in after-hours trading.
Tilly's guided for wider-than-expected losses in the fiscal second quarter. Shares of the clothing retailer dropped 13%, to $6.41, in after-hours trading.
Oncorus said it plans to cut nearly its entire workforce and anticipates its finances won't meet its needs beyond the third quarter. Shares of the biotechnology company plunged 24%, to 14 cents, in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 01, 2023 19:23 ET (23:23 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year LAVA Therapeutics NV Chart |
1 Month LAVA Therapeutics NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
